MedTrace Logo

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

NCT01198834 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2018-01-17

No results posted yet for this study

Summary

A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

Conditions

  • Ankle Sprains

Interventions

DRUG

MRX-7EAT

Application of up to two patches at the discretion of the investigator for up to 7 days.

DRUG

Placebo

Application of up to two patches at the discretion of the investigator for up to 7 days.

DRUG

Lidocaine

Application of up to two patches at the discretion of the investigator for up to 7 days.

DRUG

Etodolac

Application of up to two patches at the discretion of the investigator for up to 7 days.

Sponsors & Collaborators

  • MEDRx USA, Inc.

    lead INDUSTRY

Principal Investigators

  • Martine Francis · IL Pharma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01198834 on ClinicalTrials.gov